International Flavors & Fragrances Total Assets decreased by 1.5% to $25.14B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.0%, from $28.27B to $25.14B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 13.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth generally indicates business expansion, while a decline may suggest asset liquidation or a contraction in business scale.
This is the sum of all current and non-current assets owned by the company, representing the total resource base availab...
Universal financial metric used by all public companies to define the size of the balance sheet.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $40.86B | $40.25B | $39.66B | $39.75B | $39.30B | $34.54B | $35.52B | $35.47B | $34.46B | $33.40B | $30.98B | $30.64B | $29.54B | $29.93B | $28.72B | $28.27B | $26.12B | $25.77B | $25.54B | $25.14B |
| QoQ Change | — | -1.5% | -1.5% | +0.2% | -1.1% | -12.1% | +2.9% | -0.1% | -2.9% | -3.1% | -7.2% | -1.1% | -3.6% | +1.3% | -4.0% | -1.6% | -7.6% | -1.4% | -0.9% | -1.5% |
| YoY Change | — | — | — | — | -3.8% | -14.2% | -10.4% | -10.8% | -12.3% | -3.3% | -12.8% | -13.6% | -14.3% | -10.4% | -7.3% | -7.8% | -11.6% | -13.9% | -11.1% | -11.0% |
| Segment | Q4 '21 | Q4 '22 | Q4 '23 |
|---|---|---|---|
| Nourish | $17.45B | $17.06B | $12.89B |
| Health & Biosciences | $14.77B | $10.92B | $10.67B |
| Scent | $4.08B | $4.31B | $4.27B |
| Pharma Solutions | $3.36B | $3.23B | $3.15B |
| Total | $39.66B | $35.52B | $30.98B |
Health & Biosciences, Nourish, Pharma Solutions, Scent were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.